Technology in Cancer Research & Treatment (TCRT) is Recruiting Section Editors
We’re currently looking for Section Editors in the following key areas and would be delighted for you to join our editorial leadership team:
  • Cancer Biology: This section aims to share fundamental and translational insights into the molecular and cellular mechanisms driving cancer development and progression.
  • Detection: This section aims to share advances in biomarker discovery, biopsy techniques, and novel tools for early and accurate cancer detection.
  • Diagnosis & Prognosis: This section aims to share research that enhances diagnostic precision and prognostic assessment across cancer types.
  • Treatment: This section aims to share therapeutic strategies, including chemotherapies, immunotherapies, surgery, radiotherapy, targeted therapies and combination treatments.
To learn more about this opportunity, please view our information page. To be considered, applicants should hold a faculty position, possess an H-index of 20 or higher, have a strong publication record in the field and demonstrate a commitment to ethical open access publishing. By submitting this form you are agreeing to be contacted about this opportunity. 

Question Title

* First Name

Question Title

* Last Name

Question Title

* Email Address

Question Title

* Institution

Question Title

* H-index

Question Title

* Publication record link (WoS, Scopus, ORCiD or Google Scholar)

Question Title

* Primary area of Interest (Please select the area that best aligns with your primary expertise and research focus: Only one option should be selected)

Question Title

* What do you hope to achieve in this position?

Question Title

* Please describe your research interests.

Question Title

* CV Upload

PDF, DOC, DOCX, PNG, JPG, JPEG, GIF file types only.
Choose File
By submitting this form, you agree to opt in (and/or resubscribe) to receive relevant messaging specific to this area of interest. You can Opt Out at any time. Please refer to our Privacy Policy or Contact Us for more details.
 
100% of survey complete.

T